帕潘立酮棕榈酸酯

帕潘立酮棕榈酸酯（CAS 199739-10-1）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

这个物质在各数据库里的编号

数据库记载的用途

• Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
• Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes.
• Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS.

它在各数据库里的别名

Paliperidone Palmitate; 199739-10-1; Invega Sustenna; xeplion; Invega Trinza; Ro 92670; RO92670; R8P8USM8FR; Ro-92670; ERZOFRI; JNS010; JNS-010; PALIPERIDONE JANSSEN; R-092670; Sustenna, Invega; INVEGA HAFYERA

计算机算出的分子描述符

数据库摘要

Paliperidone Palmitate · CAS 199739-10-1 · C39H57FN4O4. UNII R8P8USM8FR.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。